首页> 外文期刊>The Internet Journal of Pathology >A Study To Assess Trend In Seroprevalence Of Hepatitis B Virus Infection Among Blood Donors Of Southern Haryana, India
【24h】

A Study To Assess Trend In Seroprevalence Of Hepatitis B Virus Infection Among Blood Donors Of Southern Haryana, India

机译:评估印度哈里亚纳邦南部献血者血清乙型肝炎病毒感染率趋势的研究

获取原文
           

摘要

Background: Hepatitis B is one of the transfusion transmissible infections. The prevalence of this infection varies across the different geographical regions. Noting the trend in seroprevalence of hepatitis B is useful to assist the preventive strategies. The aim of this study was to determine the trend of seroprevalence of hepatitis B in southern Haryana over a five -year period. Methodology: The study was conducted at the blood bank of a tertiary care hospital serving predominantly the rural population of Southern Haryana. A retrospective analysis of blood donors over a period of five years was done to assess the seroprevalence and the trend of hepatitis B infection. ELISA was used to detect the hepatitis B surface antigen in the donors as a marker of infection. Results: A total of 11,340 blood donors were studied. 150 (1.32%) were positive, which comes under the “low prevalence (<2%) zone,” per World Health Organization (WHO) guidelines. The increasing trend in seroprevalence of hepatitis B was observed after 2009. Replacement donors and male blood donors showed higher seropositivity compared to voluntary donors and female donors. A Chi-square test was used to calculate the significance of difference between the groups. Conclusion: Southern Haryana has a low prevalence of hepatitis B in blood donors with an increasing trend in seroprevalence of hepatitis B over the last two years (i.e. 2009-11). This is an alarming situation, which needs effective preventive measures as well as improved health care delivery system. Introduction Hepatitis B is a major public health problem worldwide. Assessment of the quality of donor selection and safety of the blood supply can be estimated by monitoring the prevalence of the serologic markers of infectious disease in screening tests. Approximately 30% of the world’s population or about 2 billion persons have serological evidence of either current or past infection with hepatitis B virus1. Countries are classified based on endemicity of hepatitis B virus (HBV) infection into high (8% or more), intermediate (2-7%) or low (less than 2%) incidence countries. The prevalence of chronic HBV infection in India ranges from 2% to 10%, as shown by different studies1. India therefore comes under the intermediate to high endemicity category. Hepatitis B infection is one of the transfusion transmissible infections; hence, it is mandatory to test all blood donors for HBsAg. Sero-surveys are one of the primary methods to determine the prevalence of HBsAg. Evaluation of data on the prevalence of HBV, among blood donors permits an assessment of the occurrence of infection in the blood donor population and consequently, the assessment helps in determining the safety of the blood products. In the present retrospective study, we evaluated the seroprevalence of HBV among blood donors in rural population of southern Haryana. The study also aimed to determine the trend in hepatitis B infection and to compare the prevalence with that of other areas in India. The results of these prevalence studies should help in the creation of long-term strategies to improve public health and to prevent spreading of the disease in the local population. Material and Methods The study was conducted at the blood bank of a rural tertiary care hospital, Maharaja Agrasen Medical College, serving a predominantly rural population of southern Haryana. In this retrospective study, we reviewed 11340 healthy blood donors over a period of three years from January 2007 to December 2011. Trained personnel carefully selected the donors for donation after a complete physical examination and satisfactorily answering the donor’s questionnaire. The family members, friends or relatives of the patients were categorized as replacement donors. People who donate blood without expecting any favor in return or in voluntary blood donation camps were classified as voluntary blood donors. At the end of the blood collection, donor samples were obtained for ser
机译:背景:乙型肝炎是输血传播性感染之一。在不同的地理区域,这种感染的发生率各不相同。注意到乙型肝炎血清阳性率的趋势有助于辅助预防策略。这项研究的目的是确定哈里亚纳邦南部五年内乙型肝炎的血清流行趋势。方法:该研究是在一家三级医院的血库中进行的,该医院主要为哈里亚纳邦南部的农村人口服务。对献血者进行了为期五年的回顾性分析,以评估血清阳性率和乙型肝炎感染趋势。 ELISA用于检测供体中的乙型肝炎表面抗原作为感染的标志。结果:共研究了11340个献血者。根据世界卫生组织(WHO)指南,有150位(1.32%)阳性,属于“低流行(<2%)区域”。观察到2009年后乙型肝炎的血清阳性率呈上升趋势。与自愿捐赠者和女性捐赠者相比,替代捐赠者和男性献血者显示出更高的血清阳性。卡方检验用于计算两组之间差异的显着性。结论:哈里亚纳邦南部的献血者中乙型肝炎患病率较低,并且在过去两年中(即2009-11年)乙型肝炎的血清患病率呈上升趋势。这是一个令人震惊的情况,需要有效的预防措施以及完善的医疗保健提供系统。简介乙型肝炎是全球主要的公共卫生问题。可以通过在筛查试验中监测传染病血清学标志物的流行程度来评估对供体选择质量和血液供应安全性的评估。全世界约有30%的人口(约20亿人)具有目前或过去感染乙肝病毒的血清学证据1。根据乙型肝炎病毒(HBV)的流行性将国家分类为高(8%或更高),中(2-7%)或低(小于2%)发病率的国家。如不同的研究所示,印度的慢性HBV感染率在2%至10%之间。因此,印度属于中高等流行类别。乙型肝炎感染是输血传播的感染之一。因此,必须对所有献血者进行HBsAg检测。血清调查是确定HBsAg患病率的主要方法之一。对献血者中HBV患病率数据的评估可以评估献血者中感染的发生,因此,评估有助于确定血液制品的安全性。在本回顾性研究中,我们评估了哈里亚纳邦南部农村地区献血者中的HBV血清阳性率。该研究还旨在确定乙型肝炎感染的趋势,并与印度其他地区的患病率进行比较。这些患病率研究的结果应有助于制定长期策略,以改善公共卫生并防止疾病在当地人群中传播。资料和方法这项研究是在一家农村三级医疗医院的血库中进行的,该医院是马哈拉贾·阿格拉森医学院(Maharaja Agrasen Medical College)的血库,主要服务于哈里亚纳邦南部的农村地区。在这项回顾性研究中,我们回顾了从2007年1月到2011年12月这3年中的11340名健康献血者。受过训练的人员经过全面的身体检查后仔细选择了献血者,并令人满意地回答了献血者的问卷。患者的家庭成员,朋友或亲戚被归类为替代供体。献血时不期望任何回报或在自愿献血营中得到帮助的人被归类为自愿献血者。采血结束时,获得供体样本用于血清

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号